Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE Boosted By US Stimulus Hopes; Rolls Slides

Mon, 08th Feb 2021 08:41

(Alliance News) - London's FTSE 100 was higher in early trade on Monday, shrugging off share price falls for AstraZeneca, Rolls-Royce and Experian, as global markets got a boost from progress on US President Joe Biden's USD1.9 trillion stimulus plan.

The FTSE 100 index was up 18.62 points, or 0.3%, at 6,507.95. The mid-cap FTSE 250 index was down 41.65 points, or 0.2%, at 21,025.22. The AIM All-Share index was down 0.3% at 1,208.35.

The Cboe UK 100 index was up 0.3% at 647.13 points. The Cboe 250 was down 0.1% at 18,479.51, and the Cboe Small Companies was up 1.3% at 12,629.96.

In mainland Europe, the CAC 40 in Paris was up 0.3% while the DAX 30 in Frankfurt was 0.5% higher.

Sterling was trading at USD1.3727 on Monday morning, largely flat from USD1.3728 at the London equities close on Friday.

The euro stood at USD1.2042 on Monday morning London time, up from USD1.2025 at the European equities close on Friday.

Rolls-Royce was the worst-performing FTSE 100 stock, down 2.2%. It is planning to shut down its jet engine factories this summer due to insufficient work, the Telegraph reported on Saturday.

According to the newspaper, this is the first time Roll-Royce has done this and results from what Rolls-Royce described as a "significantly reduced" workload resulting from the Covid-19 pandemic.

The two-week closures, focused around its headquarters in Derby, will affect all of the 19,000 staff within Rolls-Royce's civil aerospace division, including 12,500 UK staff, who make airliner jet engines.

Experian fell 1.4%. It said it is continuing a "detailed forensic investigation" following a Brazilian data leak, but noted that evidence suggests its technology systems have not been compromised.

The credit checking firm noted that "data which is being illegally offered for sale on the internet, some of which may have been sourced from Serasa's non-sensitive marketing data". Serasa is a Brazilian unit owned by Experian. Like its parent, Serasa provides credit granting and validation services.

Experian said it is "continuing to carry out a detailed forensic investigation".

So far, the company explained, it knows that data offered includes photographs, social media logins, vehicles registrations, and "social security INSS", the latter concerning social security contributions in Brazil. Experian however, noted that this data is not collected by Serasa.

AstraZeneca was 0.1% lower, after South Africa temporarily suspended the AstraZeneca and Oxford University jab against a new Covid-19 variant found in the country, according to the health department and top local scientists.

The AstraZeneca-Oxford vaccine protects against the original Covid-19 strain, but its efficacy drops off substantially when it comes to the new variant called B.1.351 or 501.V2, raising serious concerns, said Shabir Madhi, the professor of vaccinology at the University of the Witwatersrand, citing a new local study involving 2,000 participants.

BDSwiss Head of Investment Research Marshall Gittler commented: "The disappointing results could raise doubts about how quickly the world will return to normal."

Paddy Power owner Flutter Entertainment rose 2.1%. Morgan Stanley raised the stock to Overweight from Equal-Weight.

Lloyds Banking also climbed 2.1% after Goldman Sachs lifted the lender to Neutral from Sell.

Benefiting as well from a ratings lift was mid-cap mining technology company Weir Group, up 4.3%. It was the best FTSE 250 performer early on Monday after Morgan Stanley raised the stock to Overweight from Equal-Weight.

Share price falls for pub owners JD Wetherspoon, down 3.5%, and Mitchells & Butlers, 2.0% lower, weighed on the mid-cap index.

The Daily Telegraph over the weekend reported the prospect of dry pubs was being discussed as an option to allow bars to open their doors in April but UK government sources were dismissive about the idea, asking what the point of a pub without alcohol would be.

British Beer & Pub Association Chief Executive Emma McClarkin said: "Opening pubs without selling alcohol is not 'reopening' pubs at all."

Online retailer boohoo Group fell 2.9%. It joined online peer ASOS in snapping up retail brands from the failed Arcadia Group.

boohoo will buy the e-commerce and digital assets and associated intellectual property rights of Burton, Dorothy Perkins and Wallis for GBP25.2 million from Arcadia's joint-administrators.

"This is a great acquisition for the group as we extend our market share across a broader demographic, capitalising on growth opportunities as more and more customers shop online. We continue to grow our portfolio of brands and customer base, strengthening our position as a leader in global fashion e-commerce," boohoo Executive Chair Mahmud Kamani said.

The deal does not include any stores, however.

Arrow Global Group shares shot up 28% early on Monday. TDR Capital said it made another approach to acquire the buyer of debt from banks, credit card companies and telecommunications businesses.

TDR said the latest proposal, made on Friday, prices Arrow Global shares at 305 pence, which the private equity firm said was a 36% premium to the company's 224.0p closing price on Thursday.

A 305p offer would value all of Arrow Global at roughly GBP540 million.

On Monday, Arrow Global shares were trading at 294.00p, valuing the firm at around GBP525.0 million.

TDR added that it previously made approaches at 250p per share, 265p and 290p. The most recent was shrugged off by the Arrow board in late-January.

This time, Arrow's Group Chief Investment Officer Zachary Lewy "has entered into a binding letter of support", TDR said. The private equity firm noted "he is fully supportive of the fourth proposal".

Against the yen, the dollar was trading at JPY105.53, improved from JPY105.45 at the London market close on Friday.

"The prospect of additional fiscal stimulus also continues to buoy markets. Late on Friday, the US House of Representatives gave final approval to a budget approval that would allow President Biden's USD1.9 trillion stimulus plan to be fast tracked. Over the weekend, US Treasury Secretary, Janet Yellen touted the relief package as having the potential to return the US to full employment in 2022," analysts at Lloyds said.

US futures were higher on Monday. The Dow Jones Industrial Average and S&P 500 were both called up 0.3% and the Nasdaq Composite up 0.5%.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.